Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1.08 NOK
Change Today -0.01 / -0.92%
Volume 31.1K
As of 3:39 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

bionor pharma asa (BIONOR) Snapshot

1.12 NOK
Previous Close
1.12 NOK
Day High
1.12 NOK
Day Low
1.08 NOK
52 Week High
05/4/15 - 3.33 NOK
52 Week Low
08/24/15 - 0.99 NOK
Market Cap
Average Volume 10 Days
-0.29 NOK
Shares Outstanding
Dividend Yield
Current Stock Chart for BIONOR PHARMA ASA (BIONOR)

Related News

No related news articles were found.

bionor pharma asa (BIONOR) Related Businessweek News

No Related Businessweek News Found

bionor pharma asa (BIONOR) Details

Bionor Pharma ASA, a biotechnology company, engages in developing peptide based vaccines against viral diseases, primarily human immunodeficiency virus (HIV). The company’s HIV vaccine candidates in clinical development include Vacc-4x for reducing viral load and killing virus producing cells; and Vacc-C5, a humoral (antibody-mediated) peptide-based therapeutic HIV-1 vaccine. The company is also developing Vacc-HIV, a preclinical phase vaccine, using the combination of Vacc-4x and Vacc-C5 vaccines; and Vacc-FLU, a preclinical phase influenza vaccine. In addition, it is developing vaccines for other viral diseases, including Hepatitis C, cytomegalovirus infection, and human papillomavirus infection. Further, the company provides nutraceutical products, such as Nutri5 and NutriPro. It operates in Norway and Europe, including Russia. The company was formerly known as Nutri Pharma ASA and changed its name to Bionor Pharma ASA in June 2010. Bionor Pharma ASA was founded in 1993 and is based in Oslo, Norway.

10 Employees
Last Reported Date: 04/13/15
Founded in 1993

bionor pharma asa (BIONOR) Top Compensated Officers

Head of Development and Executive Vice Presid...
Total Annual Compensation: 1.9M NOK
Compensation as of Fiscal Year 2013.

bionor pharma asa (BIONOR) Key Developments

Bionor Pharma ASA Announces Earnings Results for the Second Quarter of 2015

Bionor Pharma ASA announced earnings results for the second quarter of 2015. For the quarter, the company's net loss amounted to NOK 21.3 million against NOK 17.0 million a year ago. Net cash outflow was NOK 19.7 million against NOK 21.0 million a year ago. Cash and cash equivalents at 30 June 2015 was NOK 55.5 million.

Bionor Pharma ASA - Analyst/Investor Day

To present the company's strategy, current highlights and next steps for value creation

Bionor Pharma ASA Reports Unaudited Earnings Results for the Six Months Ended June 30, 2015

Bionor Pharma ASA reported unaudited earnings results for the six months ended June 30, 2015. For the period, the company’s net loss amounted to NOK 21.3 million against of NOK 17.0 million for the same period a year ago. Net cash flow was NOK 19.7 million compared to NOK 21.0 million for the same period a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIONOR:NO 1.08 NOK -0.01

BIONOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIONOR.
View Industry Companies

Industry Analysis


Industry Average

Valuation BIONOR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,748.8x
Price/Book 2.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,458.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIONOR PHARMA ASA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at